Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up
about
Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort.The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC CohortCervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.Risk of Human Papillomavirus (HPV) Infection and Cervical Neoplasia after Pregnancy.Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria.HPV infection: immunological aspects and their utility in future therapyChlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study.Does the vaginal microbiota play a role in the development of cervical cancer?Socio-demographic and reproductive determinants of cervical neoplasia in seven sub-Sahara African countries.Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer.Risk factors for treatment failure following cold coagulation cervical treatment for CIN pathology: a cohort-based study.Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil.Efficacy of thermoablation in treating cervical precancerous lesions in a low-resource setting.Comparison of cure rates in women treated with cold-coagulation versus LLETZ cervical treatment for CIN2-3 on pretreatment cervical punch biopsies: a retrospective cohort study.Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.
P2860
Q35074628-F95768AA-DD59-470F-B4EA-76A4C10B362BQ35903393-5B0F5C3E-A16F-4039-BCE4-5D355476A735Q35985481-E8F249F7-61C9-47D2-9602-26EF3D60F011Q36135097-236072F7-A00E-4BFC-9879-3FC757B3FB86Q36901781-2EEA44EB-F9C0-4BAD-A783-CCBF653C7232Q37145093-B9A9D8DE-DD29-4928-9593-5F896BFD6B6AQ37844517-0E39F86E-CF68-4096-823A-DF5618E62F5CQ38376969-AF98C2D5-6EF4-4185-A563-985FE844C445Q38835933-347B75E5-4A49-40C6-9EDC-38FFC2C00D93Q39285081-FD5FFA34-17C1-446B-A1BD-16E5EDA2758DQ40648836-E9A48316-6B30-4BE5-885E-427F89EB7FD1Q40905270-F1B05F1A-9057-4647-A251-B37F5F76C54AQ41834631-1F0F9046-9270-427D-B299-8AC49CACE757Q47129353-2BFA255E-C906-412F-B026-6D9DB9945E45Q52902869-E8C7C210-A51E-4495-AA19-12AA87A7AC2BQ54232154-350BAD3E-52C6-474F-AE73-E5F317E76DFB
P2860
Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Parity as a cofactor for high- ...... infection: a 13-year follow-up
@ast
Parity as a cofactor for high- ...... infection: a 13-year follow-up
@en
type
label
Parity as a cofactor for high- ...... infection: a 13-year follow-up
@ast
Parity as a cofactor for high- ...... infection: a 13-year follow-up
@en
prefLabel
Parity as a cofactor for high- ...... infection: a 13-year follow-up
@ast
Parity as a cofactor for high- ...... infection: a 13-year follow-up
@en
P2093
P2860
P356
P1476
Parity as a cofactor for high- ...... infection: a 13-year follow-up
@en
P2093
K E Jensen
K Frederiksen
S Schmiedel
P2860
P2888
P304
P356
10.1038/BJC.2012.513
P407
P577
2012-11-20T00:00:00Z